# Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

> **NCT00150748** · PHASE3 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 217 (actual)

## Conditions studied

- Generalized Epilepsy

## Interventions

- **DRUG:** Levetiracetam 166 mg
- **DRUG:** Levetiracetam 250 mg
- **DRUG:** Levetiracetam 500 mg

## Key facts

- **NCT ID:** NCT00150748
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150748, "Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00150748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*